Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Methods using nad(h) or nadp(h) may be susceptible to interference from sulfasalazine and sulfapyridine. currently the advia chemistry dimension dimension vista and syva instructions for use do not include interference information regarding these two drugs. an internal siemens investigation was completed for the advia chemistry dimension dimension vista and syva emit assays which use nad(h)/nadp(h) methodology.